top of page

Presentation: 2024 ND EPSCoR Annual conference 

November 21, 2024, Alerus Center, Grand Forks, North Dakota

Synthesis of N-[1-(4-bromophenyl)ethyl]-N-ethylformamide

Lynn

Vick

Undergraduate Student
Minot State University

Co-authors: Lioudmila I. Bobyleva, MS, Minot State University; Mikhail M. Bobylev, PhD, Minot State University

Session

Poster Session A

Poster #38

Background: Earlier, we developed a rapid procedure for the Leuckart reaction and successfully applied it for synthesis of substituted N-(1-phenylethyl)formamides. Specifically, the reaction between 4-bromoacetophenone and formamide was completed in 15 minutes, producing N-[1-(4-bromophenyl)ethyl]formamide with isolated yield of 75%. The new procedure appeared to be much faster than the traditional Leuckart reaction, usually completed within 3-6 hours. Later, we conducted the reaction between 4-bromoacetophenone and N-methylformamide. The reaction appeared to be slower, completed in 75 minutes. This indicated that the size of the substituent attached to the nitrogen atom of formamide plays the major role in determining the rate of the reaction. Hypothesis: Since the ethyl group in N-ethylformamide is larger than the methyl in N-methylformamide, the reaction between 4-bromoacetophenone and N-ethylformamide will proceed slower than the reaction between 4-bromoacetophenone and N-methylformamide. Methods: The reaction was conducted on a 5mmol scale at 180-209℃. Extraction and column chromatography were used for isolation of the product. NMR-spectroscopy and elemental analysis were used to determine the structure. Result: The reaction was completed in 100 minutes and produced N-[1-(4-bromophenyl)ethyl]-N-ethylformamide. Conclusion: The results of the reaction support the initial hypothesis. The reaction provides a new method for the synthesis of N-[1-(4-bromophenyl)ethyl]-N-ethylformamide. N-[1-(4-bromophenyl)ethyl]-N-ethylformamide is a new compound. Support: This research was supported by NIH grant 8 P20 GM103442-12 from the National Institute of General Medical Sciences and by the National Science Foundation under NSF EPSCoR Track-1 Cooperative Agreement OIA #1946202.

The ND-ACES NSF Track-1 cooperative agreement is a federal-state partnership to manage a comprehensive research development plan. ND EPSCoR manages the Track-1 award. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation. Current funding is provided by the State of North Dakota and NSF EPSCoR Research Infrastructure Improvement Program Track-1 (RII Track-1) Cooperative Agreement Award OIA #1946202. 

bottom of page